The results suggest that both NFκB-dependent and NFκB-independent ovarian cancer cells can be targeted for additional cell death by chemotherapy and birinapant combined treatment, though the magnitude of effect may differ based on Caspase 8 expression. The gene discussed is NFKB1; the disease is ovarian cancer.